248 related articles for article (PubMed ID: 17699722)
21. Epidermal growth factor stimulates human trophoblast cell migration through Rho A and Rho C activation.
Han J; Li L; Hu J; Yu L; Zheng Y; Guo J; Zheng X; Yi P; Zhou Y
Endocrinology; 2010 Apr; 151(4):1732-42. PubMed ID: 20150581
[TBL] [Abstract][Full Text] [Related]
22. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
Fiordalisi JJ; Keller PJ; Cox AD
Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
[TBL] [Abstract][Full Text] [Related]
23. [Correlation of expression of RhoA (RhoC and their effector ROCK-1 with malignant phenotype of ovarian cancer cells in vitro].
Han ZQ; Zhang AL; Wu MF; Liu YL; Chen G; Li FJ; Gao QL; Liao GN; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):385-8. PubMed ID: 15355639
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of RhoA-mediated SRF activation by p116Rip.
Mulder J; Ariaens A; van Horck FP; Moolenaar WH
FEBS Lett; 2005 Nov; 579(27):6121-7. PubMed ID: 16243315
[TBL] [Abstract][Full Text] [Related]
25. Galphaz inhibits serum response factor-dependent transcription by inhibiting Rho signaling.
Dutt P; Jaffe AB; Merdek KD; Hall A; Toksoz D
Mol Pharmacol; 2004 Dec; 66(6):1508-16. PubMed ID: 15326221
[TBL] [Abstract][Full Text] [Related]
26. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function.
Patyal P; Zhang X; Verma A; Azhar G; Wei JY
Cells; 2024 Feb; 13(5):. PubMed ID: 38474356
[TBL] [Abstract][Full Text] [Related]
27. Motile cilia harbor serum response factor as a mechanism of environment sensing and injury response in the airway.
Nordgren TM; Wyatt TA; Sweeter J; Bailey KL; Poole JA; Heires AJ; Sisson JH; Romberger DJ
Am J Physiol Lung Cell Mol Physiol; 2014 May; 306(9):L829-39. PubMed ID: 24610937
[TBL] [Abstract][Full Text] [Related]
28. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF.
Hill CS; Wynne J; Treisman R
Cell; 1995 Jun; 81(7):1159-70. PubMed ID: 7600583
[TBL] [Abstract][Full Text] [Related]
29. Filamin A interacts with the coactivator MKL1 to promote the activity of the transcription factor SRF and cell migration.
Kircher P; Hermanns C; Nossek M; Drexler MK; Grosse R; Fischer M; Sarikas A; Penkava J; Lewis T; Prywes R; Gudermann T; Muehlich S
Sci Signal; 2015 Nov; 8(402):ra112. PubMed ID: 26554816
[TBL] [Abstract][Full Text] [Related]
30. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
31. Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion.
Kitzing TM; Sahadevan AS; Brandt DT; Knieling H; Hannemann S; Fackler OT; Grosshans J; Grosse R
Genes Dev; 2007 Jun; 21(12):1478-83. PubMed ID: 17575049
[TBL] [Abstract][Full Text] [Related]
32. Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas.
Whitson RJ; Lee A; Urman NM; Mirza A; Yao CY; Brown AS; Li JR; Shankar G; Fry MA; Atwood SX; Lee EY; Hollmig ST; Aasi SZ; Sarin KY; Scott MP; Epstein EH; Tang JY; Oro AE
Nat Med; 2018 Mar; 24(3):271-281. PubMed ID: 29400712
[TBL] [Abstract][Full Text] [Related]
33. Histamine acting on H1 receptor promotes inhibition of proliferation via PLC, RAC, and JNK-dependent pathways.
Notcovich C; Diez F; Tubio MR; Baldi A; Kazanietz MG; Davio C; Shayo C
Exp Cell Res; 2010 Feb; 316(3):401-11. PubMed ID: 19913013
[TBL] [Abstract][Full Text] [Related]
34. RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.
Faried A; Faried LS; Kimura H; Nakajima M; Sohda M; Miyazaki T; Kato H; Usman N; Kuwano H
Eur J Cancer; 2006 Jul; 42(10):1455-65. PubMed ID: 16750623
[TBL] [Abstract][Full Text] [Related]
35. RPEL proteins are the molecular targets for CCG-1423, an inhibitor of Rho signaling.
Hayashi K; Watanabe B; Nakagawa Y; Minami S; Morita T
PLoS One; 2014; 9(2):e89016. PubMed ID: 24558465
[TBL] [Abstract][Full Text] [Related]
36. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
37. Activated G(alpha)13 impairs cell invasiveness through p190RhoGAP-mediated inhibition of RhoA activity.
Bartolomé RA; Wright N; Molina-Ortiz I; Sánchez-Luque FJ; Teixidó J
Cancer Res; 2008 Oct; 68(20):8221-30. PubMed ID: 18922893
[TBL] [Abstract][Full Text] [Related]
38. ACTA1 is inhibited by PAX3-FOXO1 through RhoA-MKL1-SRF signaling pathway and impairs cell proliferation, migration and tumor growth in Alveolar Rhabdomyosarcoma.
Hu Q; Zhu L; Li Y; Zhou J; Xu J
Cell Biosci; 2021 Jan; 11(1):25. PubMed ID: 33509264
[TBL] [Abstract][Full Text] [Related]
39. Specific induction of migration and invasion of pancreatic carcinoma cells by RhoC, which differs from RhoA in its localisation and activity.
Dietrich KA; Schwarz R; Liska M; Grass S; Menke A; Meister M; Kierschke G; Längle C; Genze F; Giehl K
Biol Chem; 2009 Oct; 390(10):1063-77. PubMed ID: 19642867
[TBL] [Abstract][Full Text] [Related]
40. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
